BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medication technology ...

"Our goal was to demonstrate that auto-programming provides an additional layer of safety than the stand-alone technologies and by streamlining the IV medication ...

This release is available in Chinese. Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had ...

To ensure safety throughout the supply chain and in the patient’s home, providers are adopting tamper-evident products for intravenous home infusion. To better understand the steps home infusion ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...

Using the intranasal route to deliver medications is gaining popularity as an alternative to using intravenous therapy in emergency rooms, according to a paper published in Annals of Emergency ...

Ten of the 60 cytotoxic products on the market contained ethanol at concentrations of up to 790 mg/mL, depending on the drug, formulation, and supplier. Several final preparations contained more than ...

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer ...

The following article was originally published in Preventing Infection in Ambulatory Care, the quarterly e-publication from the Association for Professionals in Infection Control and Epidemiology ...